Back to User profile » Dr Jingfeng Zong

Papers published by Dr Jingfeng Zong:


Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum]

Guo Q, Chen M, Xu H, Lu T, Zhou H, Chen Y, Zong J, Xu Y, Chen B, Wang B, Zhu L, Pan J, Lin S

Cancer Management and Research 2020, 12:2365-2366

Published Date: 31 March 2020

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma

Lu T, Chen Y, Li J, Guo Q, Lin W, Zheng Y, Su Y, Zong J, Lin S, Ye Y, Pan J

OncoTargets and Therapy 2020, 13:1757-1765

Published Date: 26 February 2020

Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience

Guo Q, Chen M, Xu H, Lu T, Zhou H, Chen Y, Zong J, Xu Y, Chen B, Wang B, Zhu L, Pan J, Lin S

Cancer Management and Research 2020, 12:1387-1396

Published Date: 25 February 2020

Stanniocalcin 2 (STC2) Expression Promotes Post-Radiation Survival, Migration and Invasion of Nasopharyngeal Carcinoma Cells [Corrigendum]

He H, Qie S, Guo Q, Chen S, Zou C, Lu T, Su Y, Zong J, Xu H, He D, Xu Y, Chen B, Pan J, Sang N, Lin S

Cancer Management and Research 2019, 11:10409-10410

Published Date: 11 December 2019

Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells

He H, Qie S, Guo Q, Chen S, Zou C, Lu T, Su Y, Zong J, Xu H, He D, Xu Y, Chen B, Pan J, Sang N, Lin S

Cancer Management and Research 2019, 11:6411-6424

Published Date: 11 July 2019